Category: Oncology/Hematology
Global Oncology/Hematology
-
Global Liver Cancer Drugs Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $1,442.5 Million in 2022, and is anticipated to reach $4,029.6 Million by 2031, registering a CAGR of 12.16%. ... Read More
-
Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Mycosis Fungoides - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Global Photomedicine Market Size Study & Forecast, by Technology (Lasers, Polychromatic Polarized Light, Full Spectrum Light, Dichroic Lamps, Light Emitting Diodes, Fluorescent Lamps) by Application (Dermatology, Pain Management, Oncology, Ophthalmology, Wound Healing, Dental Procedures, Aesthetics, Others) and Regional Analysis, 2023-2030
... Others) and Regional Analysis, 2023-2030 Global Photomedicine Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period ... Read More
-
Global Oligonucleotide Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Hematology Market Size, Trends, Analysis, and Outlook By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers, Others), By Reagent (Coagulation Reagents, Flow Cytometry Reagents, Immun-hematology Reagents, Others), By Application (Drug Testing, Auto-immune Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-testing, Others), by Country, Segment, and Companies, 2024-2032
... Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-testing, Others), by Country, Segment, and Companies, 2024-2032 The global Hematology market size is poised to register 5.8% growth from 2024 ... Read More
-
Minimal Residual Disease (MRD) Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Flow Cytometry, Polymerase Chain Reaction, Next Generation Sequencing, Others), By Application (Leukemia, Lymphoma, Multiple Myeloma, Others), By End User (Hospitals & Specialty Clinics, Academic & Research Institutions, Clinical Laboratories, Others), By Region and Competition, 2019-2029F
... End User (Hospitals & Specialty Clinics, Academic & Research Institutions, Clinical Laboratories, Others), By Region and Competition, 2019-2029F Global Minimal Residual Disease (MRD) Testing Market was valued at USD 1.33 Billion in 2023 and is ... Read More
-
Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Beta Blockers, Antidepressants, Statins, Proton Pump Inhibitors, Benzodiazepines, Others), By Therapeutic Area (Oncology, Diabetes, Hepatitis C, Cardiovascular, Others), By Region and Competition, 2019-2029F
... By Region and Competition, 2019-2029F Global Me Too Drugs Market was valued at USD 364.81 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.87% through ... Read More
-
Companion Diagnostic Tests in Oncology Market (Detection Technique: Protein Detection, DNA Detection, and Others; and Biomarker: EGFR, KRAS, HER2, BRAF V600E, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Diagnostic Tests in Oncology Market – Scope of Report TMR’s report on the global companion diagnostic tests in oncology market studies the past as well as the current growth trends and opportunities to gain valuable ... Read More
-
Global Soft Tissue Sarcoma Targeted Drugs Market Growth (Status and Outlook) 2024-2030
... it is expected to grow at a CAGR of % from 2024 to 2030. LPI (LP Information)' newest research report, the “Soft Tissue Sarcoma Targeted Drugs Industry Forecast” looks at past sales and reviews total ... Read More
-
2024 Global Cancer Supportive Care Drugs Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
Ovarian Cancer Therapeutics
... by 2030, growing at a CAGR of 15.3% over the period 2023-2030. PARP Inhibitors, one of the segments analyzed in the report, is expected to record 16.5% CAGR and reach US$12.8 Billion by the end ... Read More
-
2024 Global Cancer Immunotherapy Industry (2030 Outlook)
... reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total value of ... Read More
-
Next Generation Sequencing Market By PRODUCT (Consumables, Platforms, Services), By APPLICATION (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized medicine, Agriculture and animal research, Others), By TECHNOLOGY (Sequencing By synthesis (SBS), Ion semiconductor sequencing (IOS), Sequencing By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
... By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035 The next generation sequencing ... Read More
-
2024 Global Cancer Monocolonal Antibodies Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
2024 Global Cancer Gene Therapy Market Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
2024 Global Cancer/Tumor Profiling Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
2024 Global Cancer Registry Software Market Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
Global Prostate Cancer Antigen 3 Test Market Insights, Forecast to 2030
... at a CAGR of 9.09% during 2024-2030. The US & Canada market for Prostate Cancer Antigen 3 Test is estimated to increase from $ 19.1 million in 2023 to reach $ 34.31 million by 2030, ... Read More
-
2024 Global Cancer Vaccine Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
2024 Global Cancer Biomarkers Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
2024 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Industry (2030 Outlook)
... (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market ... Read More
-
2024 Global Cancer Diagnostics Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and Forecast, 2023-2033
... detect and quantify the small number of cancer cells that remain in a patient's body after treatment. It involves sensitive technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and flow cytometry to identify ... Read More
-
Global Prostate Cancer Nuclear Medicine Diagnostics Market Growth (Status and Outlook) 2024-2030
... in 2023. With growing demand in downstream market, the Prostate Cancer Nuclear Medicine Diagnostics is forecast to a readjusted size of US$ 1462 million by 2030 with a CAGR of 11.0% during review period. The ... Read More
Research Assistance
